BDA Logo3.jpg
BetterLife Pharma (OTCQB:BETRF) Looks to Immune Response Drug Interferon a2b as Potential Therapeutic for COVID-19
June 19, 2020 07:56 ET | BDA International
New York City, June 19, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, announced recently that...
effector.jpg
eFFECTOR’s Zotatifin Demonstrates in vitro Anti-SARS-CoV-2 Activity in Independent International Study Reported in Peer-Reviewed Journal Nature
April 30, 2020 09:00 ET | eFFECTOR Therapeutics
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., today announced that preliminary results from an independent preclinical study showed that oncology product candidate...
RevolutionLogo.png
Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 18, 2020 16:01 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive...
logo.jpg
Dr. Adam Friedman to Present Keynote at Dermatology Fall Update
November 07, 2019 09:00 ET | Zylö Therapeutics
GREENVILLE, SC, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that its scientific advisor, Adam Friedman MD,...
Logo.png
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
October 17, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand...
Reports and Data.jpeg-01
Medical Electronics Market To Reach USD 5389.2 Million By 2026 | Reports And Data
September 04, 2019 12:15 ET | Reports and Data
New York, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Growing geriatric population, wide area of application of imaging devices and growing awareness regarding routine checkup and rising demand for easy to...
Reports and Data.jpeg-01
Dental X-Ray Market To Reach USD 3.70 Billion By 2026 | Reports And Data
August 08, 2019 09:55 ET | Reports and Data
New York, Aug. 08, 2019 (GLOBE NEWSWIRE) -- By increasing cases of oral diseases, Increasing awareness among the people about maintaining their oral health and prevent periodontal diseases, by...
Algernon Logo 1.png
Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) Exhibited Potent Anti-Fibrotic Activity in NASH and CKD Studies
July 31, 2019 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 31, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
CURE Logo.png
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019 07:25 ET | Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
Yield Growth Advances Plans to Enter the Hemp and Cannabis Beverage Business and Engages Seasoned New York Brand and Packaging Design Agency: Cornerstone Strategic Branding
May 14, 2019 08:00 ET | The Yield Growth Corp.
VANCOUVER, British Columbia, May 14, 2019 (GLOBE NEWSWIRE) -- The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt: YG3) has engaged Cornerstone Strategic Branding (CSB) headquartered in New...